Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Davide V. Moretti
Comparison of the Effects of Transdermal and Oral Rivastigmine on Cognitive Function and EEG Markers in Patients With Alzheimer’s Disease
Frontiers in Aging Neuroscience
Aging
Cognitive Neuroscience
Related publications
Slowing of EEG Background Activity in Parkinson’s and Alzheimer’s Disease With Early Cognitive Dysfunction
Frontiers in Aging Neuroscience
Aging
Cognitive Neuroscience
Brain Metabolic Stress and Neuroinflammation at the Basis of Cognitive Impairment in Alzheimer’s Disease
Frontiers in Aging Neuroscience
Aging
Cognitive Neuroscience
Impairment of Vocal Expression of Negative Emotions in Patients With Alzheimer’s Disease
Frontiers in Aging Neuroscience
Aging
Cognitive Neuroscience
Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection
Frontiers in Aging Neuroscience
Aging
Cognitive Neuroscience
Effectiveness and Tolerability of Transdermal Rivastigmine in the Treatment of Alzheimer’s Disease in Daily Practice
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Amyloid-Beta and Alzheimer’s Disease: The Role of Neprilysin-2 in Amyloid-Beta Clearance
Frontiers in Aging Neuroscience
Aging
Cognitive Neuroscience
Two Alzheimer’s Disease Risk Genes Increase Entorhinal Cortex Volume in Young Adults
Frontiers in Human Neuroscience
Mental Health
Neuropsychology
Physiological Psychology
Neurology
Behavioral Neuroscience
Psychiatry
Biological Psychiatry
The Use of Medications Approved for Alzheimer’s Disease in Autism Spectrum Disorder: A Systematic Review
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
GABAergic Neurotransmission and New Strategies of Neuromodulation to Compensate Synaptic Dysfunction in Early Stages of Alzheimer’s Disease
Frontiers in Cellular Neuroscience
Molecular Neuroscience
Cellular
